nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Temozolomide—melanoma	0.216	0.576	CbGbCtD
Tiagabine—CYP3A4—Vemurafenib—melanoma	0.119	0.316	CbGbCtD
Tiagabine—SLC6A1—Reuptake of GABA—SLC6A11—melanoma	0.078	0.329	CbGpPWpGaD
Tiagabine—CYP3A4—Docetaxel—melanoma	0.0407	0.108	CbGbCtD
Tiagabine—SLC6A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A11—melanoma	0.0224	0.0945	CbGpPWpGaD
Tiagabine—SLC6A1—GABA synthesis, release, reuptake and degradation—SLC6A11—melanoma	0.0224	0.0945	CbGpPWpGaD
Tiagabine—SLC6A1—Amine compound SLC transporters—SLC6A11—melanoma	0.0156	0.0656	CbGpPWpGaD
Tiagabine—SLC6A1—Neurotransmitter Release Cycle—SLC6A11—melanoma	0.0119	0.0501	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC39A12—melanoma	0.00955	0.0403	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.00608	0.0256	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—ITGB3—melanoma	0.00474	0.02	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—EPHA2—melanoma	0.00466	0.0197	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC6A11—melanoma	0.00439	0.0185	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00341	0.0144	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.00316	0.0133	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.00306	0.0129	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.00304	0.0128	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00276	0.0117	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC6A11—melanoma	0.00261	0.011	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ARL2—melanoma	0.00212	0.00894	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00208	0.00878	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC5A5—melanoma	0.00201	0.00845	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—melanoma	0.0019	0.00802	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00161	0.00677	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—GRIN2A—melanoma	0.0016	0.00673	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00155	0.00652	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HGF—melanoma	0.00148	0.00626	CbGpPWpGaD
Tiagabine—CYP3A4—Liver X Receptor Pathway—FASN—melanoma	0.00146	0.00614	CbGpPWpGaD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—melanoma	0.00144	0.00608	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.0014	0.00592	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—melanoma	0.00131	0.0055	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00126	0.00533	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PRKCA—melanoma	0.00109	0.00461	CbGpPWpGaD
Tiagabine—Neuropathy peripheral—Temozolomide—melanoma	0.000868	0.00224	CcSEcCtD
Tiagabine—Stomatitis—Temozolomide—melanoma	0.000863	0.00223	CcSEcCtD
Tiagabine—Urinary tract infection—Temozolomide—melanoma	0.000861	0.00222	CcSEcCtD
Tiagabine—Deafness—Docetaxel—melanoma	0.000854	0.00221	CcSEcCtD
Tiagabine—Chills—Bleomycin—melanoma	0.000846	0.00218	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—PRKCA—melanoma	0.000838	0.00353	CbGpPWpGaD
Tiagabine—Alopecia—Bleomycin—melanoma	0.000833	0.00215	CcSEcCtD
Tiagabine—Sinusitis—Temozolomide—melanoma	0.000831	0.00215	CcSEcCtD
Tiagabine—CYP3A4—Estrogen metabolism—CYP1B1—melanoma	0.000829	0.00349	CbGpPWpGaD
Tiagabine—Haemoglobin—Carmustine—melanoma	0.000827	0.00214	CcSEcCtD
Tiagabine—Haemorrhage—Carmustine—melanoma	0.000823	0.00213	CcSEcCtD
Tiagabine—Hypoaesthesia—Carmustine—melanoma	0.000819	0.00211	CcSEcCtD
Tiagabine—Hallucination—Carmustine—melanoma	0.000819	0.00211	CcSEcCtD
Tiagabine—Hypersensitivity—Vemurafenib—melanoma	0.000814	0.0021	CcSEcCtD
Tiagabine—Oedema peripheral—Carmustine—melanoma	0.000811	0.00209	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BRAF—melanoma	0.000806	0.0034	CbGpPWpGaD
Tiagabine—Dermatitis bullous—Docetaxel—melanoma	0.0008	0.00207	CcSEcCtD
Tiagabine—Haemoglobin—Temozolomide—melanoma	0.000799	0.00206	CcSEcCtD
Tiagabine—Haemorrhage—Temozolomide—melanoma	0.000795	0.00205	CcSEcCtD
Tiagabine—Asthenia—Vemurafenib—melanoma	0.000793	0.00205	CcSEcCtD
Tiagabine—Visual impairment—Carmustine—melanoma	0.000793	0.00205	CcSEcCtD
Tiagabine—Hypoaesthesia—Temozolomide—melanoma	0.000791	0.00204	CcSEcCtD
Tiagabine—Hallucination—Temozolomide—melanoma	0.000791	0.00204	CcSEcCtD
Tiagabine—Pharyngitis—Temozolomide—melanoma	0.000789	0.00204	CcSEcCtD
Tiagabine—Chills—Dactinomycin—melanoma	0.000789	0.00204	CcSEcCtD
Tiagabine—Oedema peripheral—Temozolomide—melanoma	0.000783	0.00202	CcSEcCtD
Tiagabine—Pruritus—Vemurafenib—melanoma	0.000782	0.00202	CcSEcCtD
Tiagabine—Alopecia—Dactinomycin—melanoma	0.000777	0.00201	CcSEcCtD
Tiagabine—Hyponatraemia—Docetaxel—melanoma	0.000767	0.00198	CcSEcCtD
Tiagabine—Visual impairment—Temozolomide—melanoma	0.000766	0.00198	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000764	0.00197	CcSEcCtD
Tiagabine—Ill-defined disorder—Bleomycin—melanoma	0.000761	0.00197	CcSEcCtD
Tiagabine—Anaemia—Bleomycin—melanoma	0.000758	0.00196	CcSEcCtD
Tiagabine—Diarrhoea—Vemurafenib—melanoma	0.000756	0.00195	CcSEcCtD
Tiagabine—Migraine—Docetaxel—melanoma	0.000752	0.00194	CcSEcCtD
Tiagabine—Tinnitus—Temozolomide—melanoma	0.000741	0.00192	CcSEcCtD
Tiagabine—Malaise—Bleomycin—melanoma	0.00074	0.00191	CcSEcCtD
Tiagabine—Leukopenia—Bleomycin—melanoma	0.000734	0.0019	CcSEcCtD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	0.000733	0.00309	CbGpPWpGaD
Tiagabine—Dizziness—Vemurafenib—melanoma	0.000731	0.00189	CcSEcCtD
Tiagabine—Alopecia—Carmustine—melanoma	0.000727	0.00188	CcSEcCtD
Tiagabine—Ataxia—Docetaxel—melanoma	0.000719	0.00186	CcSEcCtD
Tiagabine—Cough—Bleomycin—melanoma	0.000716	0.00185	CcSEcCtD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	0.000714	0.00301	CbGpPWpGaD
Tiagabine—Chills—Temozolomide—melanoma	0.000713	0.00184	CcSEcCtD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000713	0.00301	CbGpPWpGaD
Tiagabine—Dehydration—Docetaxel—melanoma	0.000711	0.00184	CcSEcCtD
Tiagabine—Ill-defined disorder—Dactinomycin—melanoma	0.00071	0.00183	CcSEcCtD
Tiagabine—Anaemia—Dactinomycin—melanoma	0.000707	0.00183	CcSEcCtD
Tiagabine—Liver function test abnormal—Docetaxel—melanoma	0.000706	0.00182	CcSEcCtD
Tiagabine—Vomiting—Vemurafenib—melanoma	0.000703	0.00182	CcSEcCtD
Tiagabine—Alopecia—Temozolomide—melanoma	0.000703	0.00182	CcSEcCtD
Tiagabine—Dry skin—Docetaxel—melanoma	0.000701	0.00181	CcSEcCtD
Tiagabine—Myalgia—Bleomycin—melanoma	0.000699	0.0018	CcSEcCtD
Tiagabine—Chest pain—Bleomycin—melanoma	0.000699	0.0018	CcSEcCtD
Tiagabine—Orthostatic hypotension—Docetaxel—melanoma	0.000698	0.0018	CcSEcCtD
Tiagabine—Rash—Vemurafenib—melanoma	0.000697	0.0018	CcSEcCtD
Tiagabine—Dermatitis—Vemurafenib—melanoma	0.000696	0.0018	CcSEcCtD
Tiagabine—Back pain—Carmustine—melanoma	0.000693	0.00179	CcSEcCtD
Tiagabine—Headache—Vemurafenib—melanoma	0.000692	0.00179	CcSEcCtD
Tiagabine—Discomfort—Bleomycin—melanoma	0.00069	0.00178	CcSEcCtD
Tiagabine—Malaise—Dactinomycin—melanoma	0.00069	0.00178	CcSEcCtD
Tiagabine—Leukopenia—Dactinomycin—melanoma	0.000685	0.00177	CcSEcCtD
Tiagabine—Dysgeusia—Temozolomide—melanoma	0.000678	0.00175	CcSEcCtD
Tiagabine—Confusional state—Bleomycin—melanoma	0.000675	0.00174	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—MDM2—melanoma	0.000675	0.00285	CbGpPWpGaD
Tiagabine—Tremor—Carmustine—melanoma	0.000671	0.00173	CcSEcCtD
Tiagabine—Oedema—Bleomycin—melanoma	0.00067	0.00173	CcSEcCtD
Tiagabine—Back pain—Temozolomide—melanoma	0.00067	0.00173	CcSEcCtD
Tiagabine—Infection—Bleomycin—melanoma	0.000665	0.00172	CcSEcCtD
Tiagabine—Anaemia—Carmustine—melanoma	0.000662	0.00171	CcSEcCtD
Tiagabine—Dysphagia—Docetaxel—melanoma	0.000661	0.00171	CcSEcCtD
Tiagabine—Agitation—Carmustine—melanoma	0.000658	0.0017	CcSEcCtD
Tiagabine—Nausea—Vemurafenib—melanoma	0.000657	0.0017	CcSEcCtD
Tiagabine—Thrombocytopenia—Bleomycin—melanoma	0.000656	0.00169	CcSEcCtD
Tiagabine—Myalgia—Dactinomycin—melanoma	0.000652	0.00168	CcSEcCtD
Tiagabine—Tremor—Temozolomide—melanoma	0.000648	0.00168	CcSEcCtD
Tiagabine—Discomfort—Dactinomycin—melanoma	0.000644	0.00166	CcSEcCtD
Tiagabine—Angina pectoris—Docetaxel—melanoma	0.000643	0.00166	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000642	0.00271	CbGpPWpGaD
Tiagabine—Ill-defined disorder—Temozolomide—melanoma	0.000642	0.00166	CcSEcCtD
Tiagabine—Leukopenia—Carmustine—melanoma	0.000641	0.00166	CcSEcCtD
Tiagabine—Anaemia—Temozolomide—melanoma	0.00064	0.00165	CcSEcCtD
Tiagabine—Anorexia—Bleomycin—melanoma	0.000638	0.00165	CcSEcCtD
Tiagabine—Agitation—Temozolomide—melanoma	0.000636	0.00164	CcSEcCtD
Tiagabine—Hypotension—Bleomycin—melanoma	0.000626	0.00162	CcSEcCtD
Tiagabine—Oedema—Dactinomycin—melanoma	0.000625	0.00161	CcSEcCtD
Tiagabine—Malaise—Temozolomide—melanoma	0.000624	0.00161	CcSEcCtD
Tiagabine—Vertigo—Temozolomide—melanoma	0.000622	0.00161	CcSEcCtD
Tiagabine—Infection—Dactinomycin—melanoma	0.00062	0.0016	CcSEcCtD
Tiagabine—Leukopenia—Temozolomide—melanoma	0.00062	0.0016	CcSEcCtD
Tiagabine—Hypertension—Carmustine—melanoma	0.000618	0.0016	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—BRAF—melanoma	0.000617	0.0026	CbGpPWpGaD
Tiagabine—Palpitations—Temozolomide—melanoma	0.000612	0.00158	CcSEcCtD
Tiagabine—Thrombocytopenia—Dactinomycin—melanoma	0.000612	0.00158	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00061	0.00158	CcSEcCtD
Tiagabine—Myalgia—Carmustine—melanoma	0.00061	0.00158	CcSEcCtD
Tiagabine—Chest pain—Carmustine—melanoma	0.00061	0.00158	CcSEcCtD
Tiagabine—Anxiety—Carmustine—melanoma	0.000608	0.00157	CcSEcCtD
Tiagabine—Cough—Temozolomide—melanoma	0.000604	0.00156	CcSEcCtD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—melanoma	0.000603	0.00254	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—APC—melanoma	0.000601	0.00254	CbGpPWpGaD
Tiagabine—Paraesthesia—Bleomycin—melanoma	0.000601	0.00155	CcSEcCtD
Tiagabine—Weight increased—Docetaxel—melanoma	0.000601	0.00155	CcSEcCtD
Tiagabine—Weight decreased—Docetaxel—melanoma	0.000598	0.00154	CcSEcCtD
Tiagabine—Hypertension—Temozolomide—melanoma	0.000598	0.00154	CcSEcCtD
Tiagabine—Dyspnoea—Bleomycin—melanoma	0.000597	0.00154	CcSEcCtD
Tiagabine—Anorexia—Dactinomycin—melanoma	0.000595	0.00154	CcSEcCtD
Tiagabine—Pneumonia—Docetaxel—melanoma	0.000592	0.00153	CcSEcCtD
Tiagabine—Confusional state—Carmustine—melanoma	0.000589	0.00152	CcSEcCtD
Tiagabine—Myalgia—Temozolomide—melanoma	0.000589	0.00152	CcSEcCtD
Tiagabine—Arthralgia—Temozolomide—melanoma	0.000589	0.00152	CcSEcCtD
Tiagabine—Anxiety—Temozolomide—melanoma	0.000587	0.00152	CcSEcCtD
Tiagabine—Oedema—Carmustine—melanoma	0.000585	0.00151	CcSEcCtD
Tiagabine—Discomfort—Temozolomide—melanoma	0.000582	0.0015	CcSEcCtD
Tiagabine—Decreased appetite—Bleomycin—melanoma	0.000582	0.0015	CcSEcCtD
Tiagabine—Infection—Carmustine—melanoma	0.000581	0.0015	CcSEcCtD
Tiagabine—Acute coronary syndrome—Docetaxel—melanoma	0.000581	0.0015	CcSEcCtD
Tiagabine—Renal failure—Docetaxel—melanoma	0.000579	0.0015	CcSEcCtD
Tiagabine—Neuropathy peripheral—Docetaxel—melanoma	0.000577	0.00149	CcSEcCtD
Tiagabine—Myocardial infarction—Docetaxel—melanoma	0.000577	0.00149	CcSEcCtD
Tiagabine—Dry mouth—Temozolomide—melanoma	0.000576	0.00149	CcSEcCtD
Tiagabine—Stomatitis—Docetaxel—melanoma	0.000574	0.00148	CcSEcCtD
Tiagabine—Pain—Bleomycin—melanoma	0.000573	0.00148	CcSEcCtD
Tiagabine—Conjunctivitis—Docetaxel—melanoma	0.000573	0.00148	CcSEcCtD
Tiagabine—Thrombocytopenia—Carmustine—melanoma	0.000572	0.00148	CcSEcCtD
Tiagabine—Tachycardia—Carmustine—melanoma	0.000571	0.00147	CcSEcCtD
Tiagabine—Confusional state—Temozolomide—melanoma	0.00057	0.00147	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000569	0.00147	CcSEcCtD
Tiagabine—Oedema—Temozolomide—melanoma	0.000565	0.00146	CcSEcCtD
Tiagabine—Infection—Temozolomide—melanoma	0.000561	0.00145	CcSEcCtD
Tiagabine—Anorexia—Carmustine—melanoma	0.000557	0.00144	CcSEcCtD
Tiagabine—Epistaxis—Docetaxel—melanoma	0.000556	0.00144	CcSEcCtD
Tiagabine—Thrombocytopenia—Temozolomide—melanoma	0.000553	0.00143	CcSEcCtD
Tiagabine—Feeling abnormal—Bleomycin—melanoma	0.000552	0.00143	CcSEcCtD
Tiagabine—Hypotension—Carmustine—melanoma	0.000546	0.00141	CcSEcCtD
Tiagabine—Hyperhidrosis—Temozolomide—melanoma	0.000546	0.00141	CcSEcCtD
Tiagabine—Decreased appetite—Dactinomycin—melanoma	0.000543	0.0014	CcSEcCtD
Tiagabine—Fatigue—Dactinomycin—melanoma	0.000538	0.00139	CcSEcCtD
Tiagabine—Anorexia—Temozolomide—melanoma	0.000538	0.00139	CcSEcCtD
Tiagabine—Pain—Dactinomycin—melanoma	0.000534	0.00138	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Carmustine—melanoma	0.000533	0.00138	CcSEcCtD
Tiagabine—Urticaria—Bleomycin—melanoma	0.000532	0.00137	CcSEcCtD
Tiagabine—Haemoglobin—Docetaxel—melanoma	0.000531	0.00137	CcSEcCtD
Tiagabine—Rhinitis—Docetaxel—melanoma	0.00053	0.00137	CcSEcCtD
Tiagabine—Body temperature increased—Bleomycin—melanoma	0.000529	0.00137	CcSEcCtD
Tiagabine—Haemorrhage—Docetaxel—melanoma	0.000529	0.00137	CcSEcCtD
Tiagabine—Insomnia—Carmustine—melanoma	0.000529	0.00137	CcSEcCtD
Tiagabine—Hypoaesthesia—Docetaxel—melanoma	0.000526	0.00136	CcSEcCtD
Tiagabine—Paraesthesia—Carmustine—melanoma	0.000525	0.00136	CcSEcCtD
Tiagabine—Pharyngitis—Docetaxel—melanoma	0.000525	0.00136	CcSEcCtD
Tiagabine—Dyspnoea—Carmustine—melanoma	0.000521	0.00135	CcSEcCtD
Tiagabine—Oedema peripheral—Docetaxel—melanoma	0.000521	0.00135	CcSEcCtD
Tiagabine—Somnolence—Carmustine—melanoma	0.00052	0.00134	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—MDM2—melanoma	0.000517	0.00218	CbGpPWpGaD
Tiagabine—Feeling abnormal—Dactinomycin—melanoma	0.000515	0.00133	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000515	0.00133	CcSEcCtD
Tiagabine—Insomnia—Temozolomide—melanoma	0.000511	0.00132	CcSEcCtD
Tiagabine—Gastrointestinal pain—Dactinomycin—melanoma	0.000511	0.00132	CcSEcCtD
Tiagabine—Visual impairment—Docetaxel—melanoma	0.00051	0.00132	CcSEcCtD
Tiagabine—Decreased appetite—Carmustine—melanoma	0.000508	0.00131	CcSEcCtD
Tiagabine—Paraesthesia—Temozolomide—melanoma	0.000507	0.00131	CcSEcCtD
Tiagabine—Dyspnoea—Temozolomide—melanoma	0.000504	0.0013	CcSEcCtD
Tiagabine—Somnolence—Temozolomide—melanoma	0.000502	0.0013	CcSEcCtD
Tiagabine—Constipation—Carmustine—melanoma	0.0005	0.00129	CcSEcCtD
Tiagabine—Pain—Carmustine—melanoma	0.0005	0.00129	CcSEcCtD
Tiagabine—Dyspepsia—Temozolomide—melanoma	0.000497	0.00128	CcSEcCtD
Tiagabine—Abdominal pain—Dactinomycin—melanoma	0.000494	0.00128	CcSEcCtD
Tiagabine—Body temperature increased—Dactinomycin—melanoma	0.000494	0.00128	CcSEcCtD
Tiagabine—Hypersensitivity—Bleomycin—melanoma	0.000493	0.00127	CcSEcCtD
Tiagabine—Decreased appetite—Temozolomide—melanoma	0.000491	0.00127	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCB1—melanoma	0.00049	0.00206	CbGpPWpGaD
Tiagabine—Fatigue—Temozolomide—melanoma	0.000487	0.00126	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000486	0.00205	CbGpPWpGaD
Tiagabine—Constipation—Temozolomide—melanoma	0.000483	0.00125	CcSEcCtD
Tiagabine—Pain—Temozolomide—melanoma	0.000483	0.00125	CcSEcCtD
Tiagabine—Feeling abnormal—Carmustine—melanoma	0.000482	0.00124	CcSEcCtD
Tiagabine—Asthenia—Bleomycin—melanoma	0.00048	0.00124	CcSEcCtD
Tiagabine—Gastrointestinal pain—Carmustine—melanoma	0.000478	0.00123	CcSEcCtD
Tiagabine—Chills—Docetaxel—melanoma	0.000474	0.00123	CcSEcCtD
Tiagabine—Pruritus—Bleomycin—melanoma	0.000474	0.00122	CcSEcCtD
Tiagabine—Alopecia—Docetaxel—melanoma	0.000467	0.00121	CcSEcCtD
Tiagabine—Feeling abnormal—Temozolomide—melanoma	0.000466	0.0012	CcSEcCtD
Tiagabine—Abdominal pain—Carmustine—melanoma	0.000462	0.00119	CcSEcCtD
Tiagabine—Body temperature increased—Carmustine—melanoma	0.000462	0.00119	CcSEcCtD
Tiagabine—Gastrointestinal pain—Temozolomide—melanoma	0.000462	0.00119	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—MAPK1—melanoma	0.000461	0.00194	CbGpPWpGaD
Tiagabine—Hypersensitivity—Dactinomycin—melanoma	0.00046	0.00119	CcSEcCtD
Tiagabine—Dysgeusia—Docetaxel—melanoma	0.000451	0.00116	CcSEcCtD
Tiagabine—Urticaria—Temozolomide—melanoma	0.000449	0.00116	CcSEcCtD
Tiagabine—Asthenia—Dactinomycin—melanoma	0.000448	0.00116	CcSEcCtD
Tiagabine—Abdominal pain—Temozolomide—melanoma	0.000447	0.00115	CcSEcCtD
Tiagabine—Body temperature increased—Temozolomide—melanoma	0.000447	0.00115	CcSEcCtD
Tiagabine—Back pain—Docetaxel—melanoma	0.000445	0.00115	CcSEcCtD
Tiagabine—Muscle spasms—Docetaxel—melanoma	0.000443	0.00114	CcSEcCtD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000431	0.00182	CbGpPWpGaD
Tiagabine—Hypersensitivity—Carmustine—melanoma	0.000431	0.00111	CcSEcCtD
Tiagabine—Diarrhoea—Dactinomycin—melanoma	0.000427	0.0011	CcSEcCtD
Tiagabine—Vomiting—Bleomycin—melanoma	0.000426	0.0011	CcSEcCtD
Tiagabine—Anaemia—Docetaxel—melanoma	0.000425	0.0011	CcSEcCtD
Tiagabine—Rash—Bleomycin—melanoma	0.000422	0.00109	CcSEcCtD
Tiagabine—Dermatitis—Bleomycin—melanoma	0.000422	0.00109	CcSEcCtD
Tiagabine—Asthenia—Carmustine—melanoma	0.000419	0.00108	CcSEcCtD
Tiagabine—Hypersensitivity—Temozolomide—melanoma	0.000416	0.00108	CcSEcCtD
Tiagabine—Syncope—Docetaxel—melanoma	0.000413	0.00107	CcSEcCtD
Tiagabine—Leukopenia—Docetaxel—melanoma	0.000412	0.00106	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.00041	0.00173	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000409	0.00173	CbGpPWpGaD
Tiagabine—Palpitations—Docetaxel—melanoma	0.000407	0.00105	CcSEcCtD
Tiagabine—Asthenia—Temozolomide—melanoma	0.000405	0.00105	CcSEcCtD
Tiagabine—Loss of consciousness—Docetaxel—melanoma	0.000405	0.00105	CcSEcCtD
Tiagabine—Cough—Docetaxel—melanoma	0.000402	0.00104	CcSEcCtD
Tiagabine—Diarrhoea—Carmustine—melanoma	0.0004	0.00103	CcSEcCtD
Tiagabine—Pruritus—Temozolomide—melanoma	0.0004	0.00103	CcSEcCtD
Tiagabine—Nausea—Bleomycin—melanoma	0.000398	0.00103	CcSEcCtD
Tiagabine—Hypertension—Docetaxel—melanoma	0.000397	0.00103	CcSEcCtD
Tiagabine—Vomiting—Dactinomycin—melanoma	0.000397	0.00103	CcSEcCtD
Tiagabine—Rash—Dactinomycin—melanoma	0.000394	0.00102	CcSEcCtD
Tiagabine—Arthralgia—Docetaxel—melanoma	0.000392	0.00101	CcSEcCtD
Tiagabine—Chest pain—Docetaxel—melanoma	0.000392	0.00101	CcSEcCtD
Tiagabine—Myalgia—Docetaxel—melanoma	0.000392	0.00101	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000391	0.00165	CbGpPWpGaD
Tiagabine—Dizziness—Carmustine—melanoma	0.000387	0.000999	CcSEcCtD
Tiagabine—Diarrhoea—Temozolomide—melanoma	0.000387	0.000998	CcSEcCtD
Tiagabine—Dry mouth—Docetaxel—melanoma	0.000383	0.00099	CcSEcCtD
Tiagabine—Confusional state—Docetaxel—melanoma	0.000379	0.000979	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000376	0.00158	CbGpPWpGaD
Tiagabine—Oedema—Docetaxel—melanoma	0.000376	0.00097	CcSEcCtD
Tiagabine—Dizziness—Temozolomide—melanoma	0.000374	0.000965	CcSEcCtD
Tiagabine—Infection—Docetaxel—melanoma	0.000373	0.000964	CcSEcCtD
Tiagabine—Vomiting—Carmustine—melanoma	0.000372	0.00096	CcSEcCtD
Tiagabine—Nausea—Dactinomycin—melanoma	0.000371	0.000958	CcSEcCtD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000371	0.00156	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—HRAS—melanoma	0.00037	0.00156	CbGpPWpGaD
Tiagabine—Shock—Docetaxel—melanoma	0.00037	0.000955	CcSEcCtD
Tiagabine—Rash—Carmustine—melanoma	0.000369	0.000952	CcSEcCtD
Tiagabine—Dermatitis—Carmustine—melanoma	0.000368	0.000951	CcSEcCtD
Tiagabine—Thrombocytopenia—Docetaxel—melanoma	0.000368	0.00095	CcSEcCtD
Tiagabine—Tachycardia—Docetaxel—melanoma	0.000367	0.000947	CcSEcCtD
Tiagabine—Headache—Carmustine—melanoma	0.000366	0.000946	CcSEcCtD
Tiagabine—Vomiting—Temozolomide—melanoma	0.000359	0.000928	CcSEcCtD
Tiagabine—Anorexia—Docetaxel—melanoma	0.000358	0.000925	CcSEcCtD
Tiagabine—Rash—Temozolomide—melanoma	0.000356	0.00092	CcSEcCtD
Tiagabine—Dermatitis—Temozolomide—melanoma	0.000356	0.000919	CcSEcCtD
Tiagabine—Headache—Temozolomide—melanoma	0.000354	0.000914	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—MAPK1—melanoma	0.000353	0.00149	CbGpPWpGaD
Tiagabine—Hypotension—Docetaxel—melanoma	0.000351	0.000907	CcSEcCtD
Tiagabine—Nausea—Carmustine—melanoma	0.000347	0.000897	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000342	0.000884	CcSEcCtD
Tiagabine—Insomnia—Docetaxel—melanoma	0.00034	0.000878	CcSEcCtD
Tiagabine—Paraesthesia—Docetaxel—melanoma	0.000337	0.000871	CcSEcCtD
Tiagabine—Nausea—Temozolomide—melanoma	0.000336	0.000867	CcSEcCtD
Tiagabine—Dyspnoea—Docetaxel—melanoma	0.000335	0.000865	CcSEcCtD
Tiagabine—Somnolence—Docetaxel—melanoma	0.000334	0.000863	CcSEcCtD
Tiagabine—Dyspepsia—Docetaxel—melanoma	0.000331	0.000854	CcSEcCtD
Tiagabine—Decreased appetite—Docetaxel—melanoma	0.000327	0.000844	CcSEcCtD
Tiagabine—Fatigue—Docetaxel—melanoma	0.000324	0.000837	CcSEcCtD
Tiagabine—Pain—Docetaxel—melanoma	0.000321	0.00083	CcSEcCtD
Tiagabine—Constipation—Docetaxel—melanoma	0.000321	0.00083	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000316	0.00133	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000312	0.00132	CbGpPWpGaD
Tiagabine—Feeling abnormal—Docetaxel—melanoma	0.00031	0.0008	CcSEcCtD
Tiagabine—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	0.000309	0.0013	CbGpPWpGaD
Tiagabine—Gastrointestinal pain—Docetaxel—melanoma	0.000307	0.000794	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—melanoma	0.000306	0.00129	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000305	0.00128	CbGpPWpGaD
Tiagabine—Abdominal pain—Docetaxel—melanoma	0.000297	0.000767	CcSEcCtD
Tiagabine—Body temperature increased—Docetaxel—melanoma	0.000297	0.000767	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000285	0.0012	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—HRAS—melanoma	0.000284	0.0012	CbGpPWpGaD
Tiagabine—Hypersensitivity—Docetaxel—melanoma	0.000277	0.000715	CcSEcCtD
Tiagabine—Asthenia—Docetaxel—melanoma	0.00027	0.000696	CcSEcCtD
Tiagabine—Pruritus—Docetaxel—melanoma	0.000266	0.000687	CcSEcCtD
Tiagabine—Diarrhoea—Docetaxel—melanoma	0.000257	0.000664	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000256	0.00108	CbGpPWpGaD
Tiagabine—Dizziness—Docetaxel—melanoma	0.000248	0.000642	CcSEcCtD
Tiagabine—Vomiting—Docetaxel—melanoma	0.000239	0.000617	CcSEcCtD
Tiagabine—Rash—Docetaxel—melanoma	0.000237	0.000612	CcSEcCtD
Tiagabine—Dermatitis—Docetaxel—melanoma	0.000237	0.000611	CcSEcCtD
Tiagabine—Headache—Docetaxel—melanoma	0.000235	0.000608	CcSEcCtD
Tiagabine—Nausea—Docetaxel—melanoma	0.000223	0.000576	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.000183	0.000771	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000162	0.000682	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.00016	0.000673	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP1B1—melanoma	0.000136	0.000574	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	0.000134	0.000566	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACER3—melanoma	9.08e-05	0.000383	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UGT2B10—melanoma	8.3e-05	0.00035	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HS3ST5—melanoma	7.72e-05	0.000325	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLCB4—melanoma	5.85e-05	0.000247	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIP4K2A—melanoma	5.5e-05	0.000232	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC6A11—melanoma	5.5e-05	0.000232	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTAP—melanoma	5.35e-05	0.000226	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PHGDH—melanoma	4.77e-05	0.000201	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LUM—melanoma	4.77e-05	0.000201	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HPSE—melanoma	4.68e-05	0.000197	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CUBN—melanoma	4.59e-05	0.000194	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CSPG4—melanoma	4.43e-05	0.000187	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BSG—melanoma	4.43e-05	0.000187	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SDHD—melanoma	4.43e-05	0.000187	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPAM—melanoma	4.29e-05	0.000181	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PLA2G6—melanoma	3.65e-05	0.000154	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—VCAN—melanoma	3.28e-05	0.000138	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP17A1—melanoma	2.77e-05	0.000117	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GNA11—melanoma	2.61e-05	0.00011	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FASN—melanoma	2.56e-05	0.000108	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC5A5—melanoma	2.52e-05	0.000106	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CD44—melanoma	2.43e-05	0.000102	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GNAQ—melanoma	2.43e-05	0.000102	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP1B1—melanoma	2.33e-05	9.82e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCB1—melanoma	1.92e-05	8.09e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PRKCA—melanoma	1.77e-05	7.44e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ERCC2—melanoma	1.75e-05	7.38e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CG—melanoma	1.38e-05	5.83e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARG—melanoma	1.33e-05	5.63e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CD—melanoma	1.22e-05	5.12e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—melanoma	1.2e-05	5.06e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CB—melanoma	1.06e-05	4.47e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—melanoma	1.05e-05	4.43e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTEN—melanoma	9.16e-06	3.86e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CA—melanoma	6.46e-06	2.72e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—melanoma	5.28e-06	2.22e-05	CbGpPWpGaD
